press & MEDIA INFORMATION

---

ALS TDI is committed to providing information about its research efforts to the entire ALS Community as soon as possible. The following is a list of selected items which highlight recent accomplishments of ALS TDI. For more information, or to request a press-kit, please email info@als.net.

About ALS TDI

• Corporate Brochure and Mission Statement
• Selected Short Videos
• Take a Virtual Lab Tour

Press Releases

• ALS Therapy Development Institute Receives $1.6 million Grant from the Department of Defense for Lou Gehrig's disease Research (January 12, 2010)
• Muscular Dystrophy Association Renews Partnership with ALS Therapy Development Institute to Develop New Treatments for Lou Gehrig's Disease (January 6, 2010)
• ALS Therapy Development Institute Partners with Applied Proteomics, Inc. to Develop Protein Based Biomarkers for Amyotrophic Lateral Sclerosis (December 14, 2009)
• Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Game on July 4th (July 3, 2009)
• Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States (May 18, 2009)
• ALS Therapy Development Institute; the world's largest non-profit biotech, appoints Steve Perrin, Ph.D. as Chief Executive Officer (May 1, 2009)
• ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs (April 28, 2009)
• ALS TDI and Major League Baseball Form "4ALS Awareness" Team to Combat Lou Gehrig's Disease (February 3, 2009)
• ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrig's Disease (January 20, 2009)
• ALS Therapy Development Institute Awarded $1 Million Grant (October 28, 2008)
• ALS Patients and Researchers Unite for 4th Annual Leadership Summit (September 24, 2008)
• ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease (August 19, 2008)
• ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration (July 28, 2008)
• ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science (April 08, 2008)
• Scientists Discover Why Animal Studies May Lead to Ineffective ALS Drugs (January 22, 2008)
• ALS Therapy Development Institute Signs Aptabody™ Discovery Agreement with Aptagen (January 7, 2008)
• ALS Researchers to Share Ideas with Each Other and Patients During Event at Museum of Science (October 16, 2007)
• ALS Therapy Development Institute Signs Manufacturing Agreement with Microbix Biosystems Inc. High Quality Adenoviral Production (October 16, 2007)
• ALS TDI Completes Gene Expression Profile of Lou Gehrig's Disease in Mice (October 2, 2007)

ALS TDI Annual Reports (Full Listing)

• Audited 2008 Form 990
• 2008 Annual Report
• 2007 Annual Report & Financial Statements
• 2006 Annual Report & Financial Statements

ALS TDI Newsletters (Full Listing)

• Summer 2009
• Winter/Spring 2009
• Summer/Fall 2008
• Winter 2008
• Fall 2007